Author's posts
Seth Klarman Gains Stake In Akebia Therapeutics
Klarman’s Kleryx holding transitions into stake in fully integrated kidney care company with investor’s approval
Andreas Halvorsen Discloses Stake In Urovant Sciences
Halvorsen’s Viking made one of the largest-ever private biotech investments in its parent company
David Einhorn’s Greenlight Drops 15% In 1st Half 2018
Short positions boast highest returns in the market
Steven Cohen Keeps Buying Acadia Pharmaceuticals, A Stock Down By Half This Year
The FDA said it would re-examine the company’s only drug sending shares tumbling
